Sign in
Explore the registryTrack Asciminib's trials

ASC2ESCALATE

Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

AsciminibOngoingActive not recruitingPhase 2Open NCT05384587 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…